Skip to main content
Wockhardt Limited (NSE:WOCKPHARMA)
India flag India · Delayed Price · Currency is INR
1,269.20
-30.40 (-2.34%)
Mar 9, 2026, 3:29 PM IST

Wockhardt Revenue

Wockhardt had revenue of 8.88B INR in the quarter ending December 31, 2025, with 23.16% growth. This brings the company's revenue in the last twelve months to 31.74B, up 5.76% year-over-year. In the fiscal year ending March 31, 2025, Wockhardt had annual revenue of 30.35B with 7.24% growth.

Revenue (ttm)
31.74B
Revenue Growth
+5.76%
P/S Ratio
6.50
Revenue / Employee
13.82M
Employees
2,296
Market Cap
206.24B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202530.35B2.05B7.24%
Mar 31, 202428.30B1.73B6.51%
Mar 31, 202326.57B-5.73B-17.74%
Mar 31, 202232.30B5.22B19.28%
Mar 31, 202127.08B-1.36B-4.78%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Piramal Pharma 88.71B
Eris Lifesciences 30.65B
NATCO Pharma 45.63B
Gland Pharma 61.13B
Emcure Pharmaceuticals 88.50B
Alembic Pharmaceuticals 72.67B
Ajanta Pharma 52.02B
Alivus Life Sciences 25.12B
Revenue Rankings

Wockhardt News

More News